Cargando…

RANK–RANKL signalling in cancer

Oncogenic events combined with a favourable environment are the two main factors in the oncological process. The tumour microenvironment is composed of a complex, interconnected network of protagonists, including soluble factors such as cytokines, extracellular matrix components, interacting with fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Renema, Nathalie, Navet, Benjamin, Heymann, Marie-Françoise, Lezot, Frédéric, Heymann, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2016
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974605/ https://www.ncbi.nlm.nih.gov/pubmed/27279652 http://dx.doi.org/10.1042/BSR20160150

Ejemplares similares

The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases
por: Navet, Benjamin, et al.
Publicado: (2018)

Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups
por: Navet, Benjamin, et al.
Publicado: (2018)

Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations
por: Jacques, Camille, et al.
Publicado: (2018)

Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma
por: Muñoz-Garcia, Javier, et al.
Publicado: (2022)

RANK/RANKL/OPG Signalization Implication in Periodontitis: New Evidence from a RANK Transgenic Mouse Model
por: Sojod, Bouchra, et al.
Publicado: (2017)

Primary Retention of Molars and RANKL Signaling Alteration during Craniofacial Growth
por: Gama, Andrea, et al.
Publicado: (2020)

Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences
por: Heymann, Dominique
Publicado: (2012)

The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis
por: Muñoz-Garcia, Javier, et al.
Publicado: (2021)

Origins of Alterations to Rankl Null Mutant Mouse Dental Root Development
por: Gama, Andrea, et al.
Publicado: (2020)

Advances in Osteosarcoma
por: Panez-Toro, Isidora, et al.
Publicado: (2023)

Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
por: Picarda, Gaëlle, et al.
Publicado: (2013)

The Roadmap of RANKL/RANK Pathway in Cancer
por: Casimiro, Sandra, et al.
Publicado: (2021)

RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review
por: van Dam, Peter A., et al.
Publicado: (2019)

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
por: Tellez-Gabriel, Marta, et al.
Publicado: (2019)

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
por: Ségaliny, Aude I., et al.
Publicado: (2015)

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

RANK/RANKL expression in prostate cancer
por: Ohtaka, Mari, et al.
Publicado: (2016)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
por: Simatou, Aristofania, et al.
Publicado: (2020)

RANKL/RANK: from bone loss to the prevention of breast cancer
por: Sigl, Verena, et al.
Publicado: (2016)

Bone resorption: an actor of dental and periodontal development?
por: Gama, Andrea, et al.
Publicado: (2015)

Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma
por: Jubelin, Camille, et al.
Publicado: (2022)

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
por: Ando, Kosei, et al.
Publicado: (2013)

Biology of Bone Sarcomas and New Therapeutic Developments
por: Brown, Hannah K., et al.
Publicado: (2017)

RANKL-RANK signaling regulates osteoblast differentiation and bone formation
por: Cao, Xu
Publicado: (2018)

Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine
por: Tellez-Gabriel, Marta, et al.
Publicado: (2018)

Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
por: Ming, Jie, et al.
Publicado: (2020)

The RANK–RANKL–OPG System: A Multifaceted Regulator of Homeostasis, Immunity, and Cancer
por: De Leon-Oliva, Diego, et al.
Publicado: (2023)

Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Interface in Osteoarthritis
por: Kovács, Béla, et al.
Publicado: (2019)

RANK, RANKL and osteoprotegerin in bone biology and disease
por: Wright, H. L., et al.
Publicado: (2009)

RANK/RANKL/OPG system in the intervertebral disc
por: Takegami, Norihiko, et al.
Publicado: (2017)

RANK/RANKL/OPG Signaling in the Brain: A Systematic Review of the Literature
por: Glasnović, Anton, et al.
Publicado: (2020)

Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3A
por: de Ridder, Daniëlle, et al.
Publicado: (2018)

ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells
por: Danieau, Geoffroy, et al.
Publicado: (2021)

Osteoclast regulation of osteoblasts via RANK-RANKL reverse signal transduction in vitro
por: Zhang, Shiqian, et al.
Publicado: (2017)

A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway
por: Raju, Rajesh, et al.
Publicado: (2011)

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
por: AlQranei, Mohammed S., et al.
Publicado: (2021)

RANK/RANKL pathway in cancer: Biological activity beyond bone?
por: Pantano, Francesco, et al.
Publicado: (2012)

Soy Isoflavones and Bone Health: Focus on the RANKL/RANK/OPG Pathway
por: Hooshiar, Saeedeh Hosseini, et al.
Publicado: (2022)

SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression
por: Lézot, Frédéric, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_al22lje3s2vktnnt4ajne4avap